articles
Bold Journey Spotlights RLS Founder & CEO Shaherah Yancy
In a recent feature on Bold Journey, RLS Founder and CEO Shaherah Yancy shared her personal journey — from being
In a recent feature on Bold Journey, RLS Founder and CEO Shaherah Yancy shared her personal journey — from being
“I don’t trust people who have never failed at something.” That’s what my friend said yesterday, and I agree! With
Launching a medical device in the next 1-3 years? Seeking funding for your medtech startup?Investing in a startup company? Here
Clinical data is the gateway to achieving market access and market adoption for medical device and drug innovations. With increasing
The FDA Pre-Submission (pre-sub) program is a game-changer for medtech and pharma companies. It allows you to get valuable feedback
Innovation in medical devices is vital to advancing healthcare, yet the journey from concept to market adoption remains a formidable
PMA (Premarket Approval) is the FDA’s most rigorous regulatory pathway, required for Class III medical devices, which support or sustain
The De Novo pathway is for low- to moderate-risk devices that have no existing predicate and are therefore not eligible
A 510(k) is a premarket submission to the FDA that demonstrates your medical device is “substantially equivalent” to a legally
Attention MedTech Innovators and Entrepreneurs Regulatory approval is just the beginning of your journey to market success! One of the